News|Articles|January 24, 2024
Process Optimization for mAb Commercial Manufacturing
Author(s)Catalent Pharma Solutions
It is essential to have access to the right tools and expertise to support process development for biologic therapies, from the clinical trial phase to commercialization.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
2
The FDA Moves to Modernize Drug Manufacturing Registration
3
PharmTech Weekly Roundup–July 10, 2026
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5